United States · FDA National Drug Code directory
dabrafenib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17088-0212_6e71b38e-71c0-4563-814d-2911f30bf003
- Product NDC
- 17088-0212
- Form
- TABLET, FOR SUSPENSION
- Composition / generic term
- dabrafenib
- Labeler
- Novartis Pharma Stein AG
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20230316
- Source listing expiry
- 20261231
Source-listed ingredients
- DABRAFENIB MESYLATE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 25000 TABLET, FOR SUSPENSION in 1 DRUM (17088-0212-1) · 17088-0212-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →